M 173 (Metolazone 5 mg)

Pill imprint M 173 has been identified as Metolazone 5 mg.

Metolazone is used in the treatment of edema; high blood pressure and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Metolazone 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 173

Metolazone 5 mg M 173
Metolazone 5 mg M 173 Front
Metolazone 5 mg M 173 Back
Metolazone 5 mg M 173
Metolazone
Imprint:
M
173
Strength:
5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazide diuretics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6173
Inactive Ingredients:
silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0024 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)